[治疗 HER2+ 乳腺癌的进展]
Marie Alexandre1, William Jacot2
1Département d'oncologie médicale, Institut du cancer de Montpellier, Montpellier, France. Faculté de médecine de Montpellier-Nîmes, université de Montpellier, Montpellier, France.
在HER2阳性乳腺癌治疗方面的进展,包括单克隆抗体和抗体药物合物 (ADC),已经显著改善了患者的治疗结果. 这些向疗法正在彻底改变局部化和转移性HER2+乳腺癌的护理.
科学领域:
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
